Graduated in Biology from the Federal University of São Carlos. During the undergraduate studies, received two different grants working with recombinant BCG in bladder cancer immunotherapy at the Instituto Butantan. Currently a Master's student at the Immuno-Oncology Laboratory at A.C.Camargo Cancer Center, conducting research on the epigenetic modulation of immune cells in the context of breast cancer. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
As the tumor evolves, an immunosuppressive tumor microenvironment (TME) emerges and, as a result, immune cells become dysfunctional and lose the ability to eliminate tumor cells. In this sense, NK cells lose their ability to produce cytotoxic granules and thus become incapable of effectively destroying tumor cells. Immune checkpoint inhibitors (ICI), such as anti-PD1 and anti-CTLA-4, can …
Bladder cancer is one of the top ten most common cancers in the world, accounting for 90% of all urothelial malignancies. Approximately 70% of bladder tumors are non-muscle invasive at diagnosis and are treated with transurethral resection followed by intravesical Bacillus Calmette-Guérin instillation (BCG). This bacterium is used in cancer adjuvant therapy to reduce recurrence and metast…
| 1 / 1 | Ongoing scholarships in Brazil |
| 1 / 1 | Completed scholarships in Brazil |
| 2 / 2 | All Scholarships |
| Associated processes | |
CV Lattes
ORCID